Abdel-Meguid Azza M, Awad Sara M, Noaman Mostafa, Abdel Gawad Asmaa M, Abou-Taleb Doaa A E
Faculty of Medicine, Department of Dermatology, Venereology, and Andrology, Assiut University Hospitals, Assiut, Egypt.
Faculty of Medicine, Neuropsychiatry Department, Assiut University Hospitals, Assiut, Egypt.
J Public Health Res. 2024 Apr 17;13(2):22799036241243268. doi: 10.1177/22799036241243268. eCollection 2024 Apr.
Urticaria affects a wide range of daily activities and social relationships. It has a severe impact on quality of life (QOL) and causes psychological problems.
was to assess the impact of chronic urticaria (CU) on quality of sleep, the levels of depression, anxiety, QOL and their interaction with each other and their relation to disease related factors.
The study included 25 patients with CU and 25 healthy controls. Urticaria Activity Score (UAS) was used for objective evaluation of the intensity of urticaria. Patients completed a 10-cm visual analogue score (VAS) indicating the overall severity of their itching over the previous 2 weeks. The Dermatology Life Quality Index (DLQI) was used to evaluate patients' QOL. Patients were also assessed for anxiety and depression with the Hospital Anxiety and Depression Scale (HADS). Pittsburgh Sleep Quality Index (PSQI) was used for evaluation of sleep quality and sleep disturbances.
In our CU patients the mean of UAS7 score was 39.72 ± 2.76 and the mean of VAS score was 28 ± 1.34. The mean of DLQI score was 24.8 ± 4.37 indicating severe impact of QOL. CU patients had higher total HADS score when compared to controls; 72% of the patients had depression and 92% had anxiety. By using PSQI, CU patients had significantly longer sleep latency onset, shorter total sleep duration, lower sleep efficiency and higher PSQI scores compared to controls.
CU highly affects the QOL of patients and is associated with higher levels of anxiety, depression and poor sleep quality.
荨麻疹会影响广泛的日常活动和社会关系。它对生活质量(QOL)有严重影响,并会引发心理问题。
评估慢性荨麻疹(CU)对睡眠质量、抑郁水平、焦虑水平、生活质量的影响,以及它们之间的相互作用及其与疾病相关因素的关系。
该研究纳入了25例慢性荨麻疹患者和25名健康对照者。荨麻疹活动评分(UAS)用于客观评估荨麻疹的严重程度。患者完成了一个10厘米的视觉模拟评分(VAS),表明其过去2周内瘙痒的总体严重程度。皮肤病生活质量指数(DLQI)用于评估患者的生活质量。还使用医院焦虑抑郁量表(HADS)对患者的焦虑和抑郁进行评估。匹兹堡睡眠质量指数(PSQI)用于评估睡眠质量和睡眠障碍。
在我们的慢性荨麻疹患者中,UAS7评分的平均值为39.72±2.76,VAS评分的平均值为28±1.34。DLQI评分的平均值为24.8±4.37,表明生活质量受到严重影响。与对照组相比,慢性荨麻疹患者的HADS总分更高;72%的患者有抑郁,92%的患者有焦虑。通过使用PSQI,与对照组相比,慢性荨麻疹患者的睡眠潜伏期明显更长,总睡眠时间更短,睡眠效率更低,PSQI评分更高。
慢性荨麻疹对患者的生活质量有很大影响,并与更高水平的焦虑、抑郁和睡眠质量差有关。